Gene · 4633
Papers3,564
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,564
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Left Ventricular Noncompaction Cardiomyopathy in an Elderly Patient: A Case Report and Literature Review. | Cureus | 2023 | 37261174 | PubTator, text mining | PubMed |
| Cryo-EM structure of the folded-back state of human β-cardiac myosin. | Nat Commun | 2023 | 37258552 | PubTator, text mining | PubMed |
| Not All Left Ventricular Hypertrophy Is Hypertrophic Cardiomyopathy: MYL2-Associated Double-Chambered Left Ventricle. | Can J Cardiol | 2023 | 37257752 | PubTator, text mining | PubMed |
| Systematic discovery of transcription factors that improve hPSC-derived cardiomyocyte maturation via temporal analysis of bioengineered cardiac tissues. | APL Bioeng | 2023 | 37252678 | PubTator, text mining | PubMed |
| Large-scale microRNA functional high-throughput screening identifies miR-515-3p and miR-519e-3p as inducers of human cardiomyocyte proliferation. | iScience | 2023 | 37250320 | PubTator, text mining | PubMed |
| Arrhythmogenic cardiomyopathy as a myogenic disease: highlights from cardiomyocytes derived from human induced pluripotent stem cells. | Front Physiol | 2023 | 37250123 | PubTator, text mining | PubMed |
| Arrhythmic Risk Stratification among Patients with Hypertrophic Cardiomyopathy. | J Clin Med | 2023 | 37240503 | PubTator, text mining | PubMed |
| One Billion hiPSC-Cardiomyocytes: Upscaling Engineered Cardiac Tissues to Create High Cell Density Therapies for Clinical Translation in Heart Regeneration. | Bioengineering (Basel) | 2023 | 37237658 | PubTator, text mining | PubMed |
| Pluripotent stem cell-derived committed cardiac progenitors remuscularize damaged ischemic hearts and improve their function in pigs. | NPJ Regen Med | 2023 | 37236990 | PubTator, text mining | PubMed |
| Novel Metal Nanomaterials to Promote Angiogenesis in Tissue Regeneration. | Eng Regen | 2023 | 37234753 | PubTator, text mining | PubMed |
| Left Ventricular Systolic Dysfunction in Patients Diagnosed With Hypertrophic Cardiomyopathy During Childhood: Insights From the SHaRe Registry. | Circulation | 2023 | 37226762 | PubTator, text mining | PubMed |
| An integrative review of nonobvious puzzles of cellular and molecular cardiooncology. | Cell Mol Biol Lett | 2023 | 37221467 | PubTator, text mining | PubMed |
| AMPK is a mechano-metabolic sensor linking cell adhesion and mitochondrial dynamics to Myosin-dependent cell migration. | Nat Commun | 2023 | 37217519 | PubTator, text mining | PubMed |
| Growth hormone-releasing hormone antagonists counteract hydrogen peroxide - induced paracellular hyperpermeability in endothelial cells. | Growth Horm IGF Res | 2023 | 37210756 | PubTator, text mining | PubMed |
| Unlocking the mysteries of alpha-N-terminal methylation and its diverse regulatory functions. | J Biol Chem | 2023 | 37209820 | PubTator, text mining | PubMed |
| Unique osteogenic profile of bone marrow stem cells stimulated in perfusion bioreactor is Rho-ROCK-mediated contractility dependent. | Bioeng Transl Med | 2023 | 37206242 | PubTator, text mining | PubMed |
| Engineering a conduction-consistent cardiac patch with graphene oxide modified butterfly wings and human pluripotent stem cell-derived cardiomyocytes. | Bioeng Transl Med | 2023 | 37206241 | PubTator, text mining | PubMed |
| HER2 inhibition increases non-muscle myosin IIA to promote tumorigenesis in HER2+ breast cancers. | PLoS One | 2023 | 37200287 | PubTator, text mining | PubMed |
| 1-Deoxynojirimycin promotes cardiac function and rescues mitochondrial cristae in mitochondrial hypertrophic cardiomyopathy. | J Clin Invest | 2023 | 37200096 | PubTator, text mining | PubMed |
| High extracellular glucose promotes cell motility by modulating cell deformability and contractility via the cAMP-RhoA-ROCK axis in human breast cancer cells. | Mol Biol Cell | 2023 | 37195739 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4633/papers?page=18